Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Alterity Therapeutics Ltd. ( (AU:ATH) ) is now available.
Alterity Therapeutics Ltd. announced a proposed issue of securities involving 3,636,363,636 fully paid ordinary shares and 1,212,121,212 options with a two-year expiry and an exercise price of $0.028. This move is positioned to bolster the company’s capital and potentially enhance its market presence, providing Alterity with greater financial resources to advance its drug development programs and solidify its standing in the biotech sector.
More about Alterity Therapeutics Ltd.
Alterity Therapeutics Ltd. operates in the biotechnology industry, focusing on developing therapeutic solutions for neurodegenerative diseases. The company is primarily involved in creating pharmaceutical products aimed at altering the progression of these diseases, with a significant focus on conditions such as Alzheimer’s and Parkinson’s.
Average Trading Volume: 100
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $41.31M
Find detailed analytics on ATH stock on TipRanks’ Stock Analysis page.